PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, is pleased to ...

Early menopause, occurring before 45, and premature menopause, before 40, mark the end of a woman's reproductive years ...

Standard first-line drug therapies for the treatment of bone density disorders have been linked to higher risk of experiencing a cardiovascular event, according to a study published June 26 in Epic ...

Mounjaro has become popular as a weight loss drug but it also seems to be linked to hair loss in some cases in a worrying new ...

Beyond basic living expenses, the single greatest threat to financial longevity may be healthcare. A Fidelity report ...

The justices ruled that a key preventive health task force has authority because it is appointed by the Health and Human ...

Parade. As we get older, even reaching down and touching our toes can be a, well, stretch. But it's never too late to ...

A bill in the California legislature would prevent health plans from denying certain treatments for menopause symptoms. The ...

Vitamin D deficiency, a widespread issue affecting billions globally, stems from insufficient sunlight exposure, diet, or ...

Residents living in and around the Elgin can learn about their risk for cardiovascular disease, osteoporosis, diabetes, and other chronic, serious conditions with affordable screenings by Life Line ...

In TODAY.com's expert tip of the day, a trainer reveals how he uses his daily walks to build and maintain strong bones as he ...

A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease. Monogenic lupus nephritis is distinct from non-monogenic disease with ...